Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB/c mice

J Immunol. 2006 Jan 15;176(2):1115-21. doi: 10.4049/jimmunol.176.2.1115.

Abstract

Expressed on various cell types, the IL-4Ralpha is a component of both receptors for IL-4 and IL-13. Susceptibility of BALB/c mice to Leishmania major is believed to be dependent on the development of IL-4- and IL-13-producing Th2 cells, while IFN-gamma secretion by Th1 cells is related to resistance. Despite a sustained development of Th2 cells, IL-4Ralpha-deficient BALB/c mice are able to control acute cutaneous leishmaniasis, suggesting that IL-4Ralpha-bearing cells other than Th2 cells contribute to susceptibility. To analyze the contribution of the IL-4Ralpha on macrophages, recently generated macrophage/neutrophil-specific IL-4Ralpha-deficient mice on a susceptible BALB/c genetic background were infected with L. major. Strikingly, macrophage/neutrophil-specific IL-4Ralpha-deficient mice showed a significantly delayed disease progression with normal Th2 and type 2 Ab responses but improved macrophage leishmanicidal effector functions and reduced arginase activity. Together, these results suggest that alternative macrophage activation contributes to susceptibility in cutaneous leishmaniasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Protozoan / biosynthesis
  • Interferon-gamma / biosynthesis
  • Interleukin-4 / biosynthesis
  • Interleukin-4 / pharmacology
  • Leishmania major / immunology
  • Leishmaniasis, Cutaneous / etiology*
  • Leishmaniasis, Cutaneous / immunology*
  • Leishmaniasis, Cutaneous / pathology
  • Macrophage Activation*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Receptors, Cell Surface / deficiency
  • Receptors, Cell Surface / genetics
  • Recombinant Proteins / pharmacology
  • Th1 Cells / immunology
  • Th2 Cells / immunology

Substances

  • Antibodies, Protozoan
  • Il4ra protein, mouse
  • Receptors, Cell Surface
  • Recombinant Proteins
  • Interleukin-4
  • Interferon-gamma